TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Sarepta Shares Rise on Positive Gene Therapy Trial Results
Play
INVESTING

Sarepta Sinks on Disappointing Gene-Therapy Study Results

  • By M. Corey Goldman
  • Jan 8, 2021 9:36 AM EST
Sarepta Shares Rise on Positive Gene Therapy Trial Results
INVESTING

Sarepta Sinks on Disappointing Gene-Therapy Study Results

  • By M. Corey Goldman
  • Jan 8, 2021 9:36 AM EST
PRESS RELEASES

Rocket Pharmaceuticals Announces Participation At The 39th Annual J.P. Morgan Healthcare Conference

  • By Business Wire
  • Jan 6, 2021 7:00 AM EST
PRESS RELEASES

Rocket Pharmaceuticals Prices Upsized Public Offering Of Common Stock

  • By Business Wire
  • Dec 9, 2020 11:32 PM EST
PRESS RELEASES

Rocket Pharmaceuticals Announces Proposed Public Offering Of Common Stock

  • By Business Wire
  • Dec 9, 2020 7:51 AM EST
PRESS RELEASES

Rocket Pharmaceuticals Announces Positive Gene Expression, Clinical Biomarker And Preliminary Functional Data From Phase 1 Trial Of RP-A501 For The Treatment Of Danon Disease

  • By Business Wire
  • Dec 8, 2020 4:00 PM EST
PRESS RELEASES

Rocket Pharmaceuticals Presents Positive Clinical Data From Its Fanconi Anemia And Leukocyte Adhesion Deficiency-I Programs At The 62nd American Society Of Hematology Annual Meeting

  • By Business Wire
  • Dec 7, 2020 2:30 PM EST
PRESS RELEASES

Rocket Pharmaceuticals To Hold Webcast For Investors Highlighting Data Presented At The 62nd American Society Of Hematology Annual Meeting

  • By Business Wire
  • Dec 2, 2020 7:00 AM EST
PRESS RELEASES

Rocket Pharmaceuticals Receives Funding From The California Institute For Regenerative Medicine For Phase 1 Clinical Trial Of RP-L401 For Infantile Malignant Osteopetrosis

  • By Business Wire
  • Nov 13, 2020 7:00 AM EST
PRESS RELEASES

Rocket Pharmaceuticals To Present Data From Its Fanconi Anemia, Leukocyte Adhesion Deficiency-I And Pyruvate Kinase Deficiency Programs At The 62nd American Society Of Hematology Annual Meeting

  • By Business Wire
  • Nov 4, 2020 10:37 AM EST
PRESS RELEASES

Rocket Pharmaceuticals Announces Participation At Upcoming Conferences

  • By Business Wire
  • Sep 24, 2020 7:00 AM EDT
PRESS RELEASES

Rocket Pharmaceuticals Announces Participation At Upcoming Conferences

  • By Business Wire
  • Sep 4, 2020 7:00 AM EDT
PRESS RELEASES

Rocket Pharmaceuticals Announces First Patient Treated In Higher Dose Cohort In Phase 1 Clinical Trial Of RP-A501 For Danon Disease

  • By Business Wire
  • Sep 2, 2020 7:00 AM EDT
PRESS RELEASES

Rocket Pharmaceuticals Receives FDA Fast Track Designation For RP-L401 Gene Therapy For Infantile Malignant Osteopetrosis

  • By Business Wire
  • Aug 27, 2020 7:00 AM EDT
PRESS RELEASES

Rocket Pharmaceuticals Expands Clinical Sites For Its FA, Danon, LAD-I And IMO Trials, Adding To Its Global Centers Of Excellence

  • By Business Wire
  • Aug 26, 2020 7:00 AM EDT
PRESS RELEASES

Rocket Pharmaceuticals Announces First Patient Treated In Phase 1 Trial Of RP-L301 Gene Therapy For Pyruvate Kinase Deficiency

  • By Business Wire
  • Jul 13, 2020 7:00 AM EDT
PRESS RELEASES

Rocket Pharmaceuticals Announces FDA Clearance Of IND For RP-L401 Gene Therapy For Infantile Malignant Osteopetrosis

  • By Business Wire
  • Jun 29, 2020 7:00 AM EDT
PRESS RELEASES

Rocket Pharmaceuticals Announces Private Exchange Transaction Regarding Its Outstanding Convertible Senior Notes Due 2021

  • By Business Wire
  • Jun 8, 2020 7:00 AM EDT
PRESS RELEASES

Rocket Pharmaceuticals Announces Participation At The Jefferies Virtual Healthcare Conference

  • By Business Wire
  • May 26, 2020 7:00 AM EDT
PRESS RELEASES

Rocket Pharmaceuticals Presents Positive Updates On FA And LAD-I Gene Therapy Programs At The 23rd Annual Meeting Of The American Society Of Gene And Cell Therapy

  • By Business Wire
  • May 12, 2020 7:00 AM EDT
PRESS RELEASES

Rocket Pharmaceuticals Announces Participation At The BofA Securities 2020 Health Care Conference

  • By Business Wire
  • May 5, 2020 7:00 AM EDT
PRESS RELEASES

Rocket Pharmaceuticals Appoints Elisabeth Bjӧrk, M.D., Ph.D. To Board Of Directors

  • By Business Wire
  • Apr 22, 2020 7:00 AM EDT
PRESS RELEASES

Rocket Pharmaceuticals Provides Business Update In Light Of COVID-19 Pandemic

  • By Business Wire
  • Apr 2, 2020 9:00 AM EDT
PRESS RELEASES

Rocket Pharmaceuticals Announces Participation At The Guggenheim Healthcare Talks: Genomic Medicines And Rare Disease Day

  • By Business Wire
  • Apr 2, 2020 7:30 AM EDT
PRESS RELEASES

Rocket Pharmaceuticals Announces Science Translational Medicine Publication Of Its Program In Danon Disease

  • By Business Wire
  • Mar 19, 2020 7:00 AM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.